Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 17 of 17 for “"CRISPR-Cas9 screening"”.

  1. Identification of novel synthetic lethal interactions using multiplexed CRISPR-Cas9 screening

    … interactions and built a bespoke multiplex CRISPR-Cas9 library to interrogate 1192 gene-pair interactions. We deployed this library on a panel of melanoma cell lines and a retinal pigment epithelial cell line as a normal comparator. We went on to develop a bioinformatic pipeline with which …

    cambridge Repository record for Identification of novel synthetic lethal interactions using multiplexed CRISPR-Cas9 screening (opens in a new tab)

  2. Defining cell state regulators in cancers using single-cell analysis and CRISPR-Cas9 screening

    … screened using a single-cell RNA-seq coupled CRISPR- knock-out approach, with regulator potential uncovered for multiple targets including SOX10, MITF, EIF3G, PRPF19, RPS27A, and CDC20. Cell line annotations achieved through previous high-throughput screens were also leveraged to uncover …

    cambridge Repository record for Defining cell state regulators in cancers using single-cell analysis and CRISPR-Cas9 screening (opens in a new tab)

  3. ESTABLISHING AN IN VITRO MODEL FOR CRISPR-CAS9 SCREENING OF INTERFERON EFFECTORS IN HBV INFECTION

    … response and sought to identify them via a CRISPR-Cas9 knockout screen targeting ~2,000 ISGs. Identifying the ISGs that mediate antiviral activity may provide insights into how interferon responses can be potentiated, both to improve patient outcomes and to increase our understanding of …

    milano Repository record for ESTABLISHING AN IN VITRO MODEL FOR CRISPR-CAS9 SCREENING OF INTERFERON EFFECTORS IN HBV INFECTION (opens in a new tab)

  4. Application of CRISPR/Cas9 screening to study cancer drivers and to identify novel cancer vulnerabilities

    … it simpler to accurately identify interactions. CRISPR/Cas9 technology was applied as it allows for large-scale, unbiased screening of genetic interactions. A genome-wide guide RNA library was prepared and implemented for knockout screening in the isogenic cell line panel. Analysis was performed …

    cambridge Repository record for Application of CRISPR/Cas9 screening to study cancer drivers and to identify novel cancer vulnerabilities (opens in a new tab)

  5. Characterisation of HIF2A targets identifies MYC as a key determinant of HIF2A dependency in ccRCC

    … could then be functionally tested by *in vivo* CRISPR/Cas9 screening and subsequent rescue experiments. CRISPR/Cas9 screening revealed that *MYC* and *CCND1* are key dependencies in ccRCC *in vivo*, in addition to highlighting key differences between *in vitro* and *in vivo* dependencies. By …

    cambridge Repository record for Characterisation of HIF2A targets identifies MYC as a key determinant of HIF2A dependency in ccRCC (opens in a new tab)

  6. Harnessing CRISPR-Cas9 screens to identify functional genetic interactions

    The advent of CRISPR-Cas9 genetic engineering technologies has vastly improved our ability to interrogate genetic interactions in high-throughput studies. CRISPR-Cas9 screens have rapidly evolved to become the main approach for unbiased, genome-wide, forward genetic studies. This work seeks to …

    cambridge Repository record for Harnessing CRISPR-Cas9 screens to identify functional genetic interactions (opens in a new tab)

  7. Utilizing in vivo genome-wide CRISPR/Cas9 screens in immunocompetent mouse models to identify novel tumor liabilities and explore mechanisms of resistance to Chimeric Antigen Receptor T-cell therapy

    … (TME). Fortunately, with the advent of CRISPR/Cas9 screening platform technologies, mechanisms of treatment resistance and novel therapeutic target identification can be efficiently interrogated in an unbiased, high-throughput manner. Furthermore, adaptation of these platforms for use in …

    mit Repository record for Utilizing in vivo genome-wide CRISPR/Cas9 screens in immunocompetent mouse models to identify novel tumor liabilities and explore mechanisms of resistance to Chimeric Antigen Receptor T-cell therapy (opens in a new tab)

  8. SMARCB1 Maintains Lineage Fidelity in Clear Cell Renal Cell Carcinoma

    … lineage factor dependence in cancer. Using CRISPR/Cas9 loss-of-function screening coupled with in vitro and in vivo validation I show that the loss of SMARCB1, a member of the SWI/SNF chromatin remodelling complex, confers an advantage to ccRCC cells upon inhibition of the essential renal …

    cambridge Repository record for SMARCB1 Maintains Lineage Fidelity in Clear Cell Renal Cell Carcinoma (opens in a new tab)

  9. The identification of novel factors required for the development of primordial germ cells

    … in vitro. Secondly, we coupled this system with CRISPR/Cas9 screening technology, which permitted us to identify novel factors required during the development of PGCLCs. We identified the translesion synthesis (TLS) factor Rev1 as a key factor involved in PGCLC development. Furthermore, we …

    cambridge Repository record for The identification of novel factors required for the development of primordial germ cells (opens in a new tab)

  10. Identification and functional characterisation of gene fusions in human cancer cell lines

    … In this study, I combine RNA sequencing, CRISPR/Cas9 screens and high-throughput drug sensitivity data in a panel of 1,011 human cancer cell lines across 42 tissue types to examine the occurrence and functional relevance of gene fusions in cancer. Fusions were called using three algorithms …

    cambridge Repository record for Identification and functional characterisation of gene fusions in human cancer cell lines (opens in a new tab)

  11. Applications of forward genetic screens to LncRNAs, cancer immunotherapy, and cellular engineering

    … mapped to phenotypic changes. Recently, CRISPR-Cas9 has emerged as a powerful genetic perturbation technology, opening up new opportunities for forward genetic screens. In this thesis, I present work to advance this approach and demonstrate its application in a range of contexts relevant …

    mit Repository record for Applications of forward genetic screens to LncRNAs, cancer immunotherapy, and cellular engineering (opens in a new tab)

  12. DISSECTION OF HOST-VIRUS INTERACTIONS IN THE HUMAN CENTRAL NERVOUS SYSTEM

    … either IAV or MPXV. By developing a genome-wide CRISPR/Cas9 screening platform in human neurons, we were able to identify several candidate host factors that regulate neuronal anti-HSV-1 immunity, such as MTBP, SIRT7, GNAI3, NPPA, POLR3E and RNGTT. In a complementary approach, we performed high …

    milano Repository record for DISSECTION OF HOST-VIRUS INTERACTIONS IN THE HUMAN CENTRAL NERVOUS SYSTEM (opens in a new tab)

  13. Genetic alterations defining human primary melanoma and mechanisms of immune evasion

    … intersect my genomic analysis with a dataset of CRISPR-Cas9 dropout screens and discover a melanoma-associated genetic vulnerability mediated by Interferon Regulatory Factor 4 (IRF4). I then begin to experimentally validate and explore the biological pathway by which IRF4 may function in the …

    cambridge Repository record for Genetic alterations defining human primary melanoma and mechanisms of immune evasion (opens in a new tab)

  14. Dissecting the early steps of MLL induced leukaemogenic transformation using a new mouse model of AML

    … MLL-ENL expression. To this end, genome-wide CRISPR-Cas9 screening was performed on the new AML model developed. The data obtained were integrated with scRNA-seq results in order to identify and validate new potential therapeutic targets associated with early MLL-ENL driven transcriptional …

    cambridge Repository record for Dissecting the early steps of MLL induced leukaemogenic transformation using a new mouse model of AML (opens in a new tab)

  15. Developing Targeted Therapies for T-cell Acute Lymphoblastic Leukemia

    … drivers for dasatinib sensitivity. Genome-wide CRISPR/Cas9 screening, phosphorylation flow cytometry, and phosphorylation proteomics assays were employed to confirm the dependency and inhibitory effect of dasatinib on its therapeutic targets (dasatinib sensitivity drivers). In vitro …

    tenn-hsc Repository record for Developing Targeted Therapies for T-cell Acute Lymphoblastic Leukemia (opens in a new tab)

  16. Viral- and host-targeted interventions to improve influenza disease outcomes

    … during severe influenza infections. Using CRISPR/Cas9 screening techniques, and a type I IFN reporter system, we identified G-protein coupled estrogen receptor 1 (GPER1) as a candidate regulator. Our subsequent experiments demonstrated that blocking GPER1 function with a selective …

    duke Repository record for Viral- and host-targeted interventions to improve influenza disease outcomes (opens in a new tab)

  17. Biases and Blind-Spots In Genome-Wide Crispr-Cas9 Knockout Screens

    <p>Adaptation of the bacterial CRISPR-Cas9 system to mammalian cells revolutionized the field of functional genomics, enabling genome-scale genetic perturbations to study essential genes, whose loss of function results in a severe fitness defect. There are two types of essential genes in a cell. …

    uthsc Repository record for Biases and Blind-Spots In Genome-Wide Crispr-Cas9 Knockout Screens (opens in a new tab)